Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-44,450
Closed -$1.19M 273
2014
Q4
$1.19M Hold
44,450
0.04% 163
2014
Q3
$1.08M Sell
44,450
-200
-0.4% -$5.05K 0.03% 171
2014
Q2
$1.13M Buy
44,650
+300
+0.7% +$7.01K 0.03% 170
2014
Q1
$954K Sell
44,350
-303,570
-87% -$6.55M 0.03% 177
2013
Q4
$7.78M Buy
+347,920
New +$7.67M 0.37% 52

Other funds holding HOLX

Cannell & Co's HOLX Position: Q1 2015 in Review

Cannell & Co sold out of Hologic (HOLX) in Q1 2015, closing a stake of 44,450 shares — an estimated $1.19M sold.

Cannell & Co first reported a position in HOLX in Q4 2013 and held it in 5 quarters. The position peaked at $7.78M in Q4 2013. 393 funds tracked by Wall St. Rank hold HOLX as of Q1 2015.

  • Cannell & Co reported no remaining Hologic position as of Q1 2015 after selling out during the quarter.
  • Cannell & Co sold 44,450 Hologic shares in Q1 2015, an estimated $1.19M.
  • Cannell & Co first reported a position in Hologic in Q4 2013 and held it in 5 quarters.
  • Cannell & Co's Hologic position peaked at $7.78M in Q4 2013.
  • 393 funds tracked by Wall St. Rank held Hologic as of Q1 2015.

Based on Cannell & Co's 13F filing for Q1 2015, filed 14 May 2015.